about
Coiled-Coil Irregularities and Instabilities in Group A Streptococcus M1 Are Required for VirulenceStreptococcal M1 protein constructs a pathological host fibrinogen networkCoiled-coil irregularities of the M1 protein structure promote M1-fibrinogen interaction and influence group A Streptococcus host cell interactions and virulence.Phenol soluble modulin (PSM) variants of community-associated methicillin-resistant Staphylococcus aureus (MRSA) captured using mass spectrometry-based molecular networking.Increased neutrophil extracellular trap-mediated Staphylococcus aureus clearance through inhibition of nuclease activity by clindamycin and immunoglobulinChemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract.DNase Sda1 allows invasive M1T1 Group A Streptococcus to prevent TLR9-dependent recognitionPorphyromonas gingivalis regulates TREM-1 in human polymorphonuclear neutrophils via its gingipains.Streptococcal SpeB cleaved PAR-1 suppresses ERK phosphorylation and blunts thrombin-induced platelet aggregation.Clonality and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus at the University Hospital Zurich, Switzerland between 2012 and 2014.M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition.Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).Importance of Toll-like receptor 9 in host defense against M1T1 group A Streptococcus infectionsHypoxia inducible factor (HIF) function in innate immunity and infection.The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing.NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha.Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections.NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activationOptimal Length of Cultivation Time for Isolation of Propionibacterium acnes in Suspected Bone and Joint Infections Is More than 7 Days.Vascular graft infections.Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux.Modulation of Staphylococcus aureus Biofilm Matrix by Subinhibitory Concentrations of Clindamycin.The CXC chemokine-degrading protease SpyCep of Streptococcus pyogenes promotes its uptake into endothelial cells.Impact of oral gut decontamination on staphylococcus aureus colonization in patients undergoing allogeneic hematopoietic stem cell transplantation.Cutaneous Corynebacterium Infection Presenting with Disseminated Skin Nodules and Ulceration.Reply to "Modulatory Effects of a Subinhibitory Concentration of Clindamycin in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains of Sequence Type 30".Reply to Perez and Patel.Type 2 Interleukin-4 Receptor Signaling in Neutrophils Antagonizes Their Expansion and Migration during Infection and Inflammation.Interferon α-Enhanced Clearance of Group A Streptococcus Despite Neutropenia.Yersinia enterocolitica-mediated degradation of neutrophil extracellular traps (NETs).Methicillin-resistant Staphylococcus aureus eradication in young infants should include the diaper area and treat housing contacts.Epidemiology of Methicillin-Susceptible Staphylococcus aureus in a Neonatology Ward.Protein adsorption steers blood contact activation on engineered cobalt chromium alloy oxide layers.Statins enhance formation of phagocyte extracellular traps.Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α.[Gram positive toxic shock syndrome].USA300 methicillin-resistant Staphylococcus aureus in Zurich, Switzerland between 2001 and 2013.Propionibacterium avidum - a virulent pathogen causing hip periprosthetic joint infection.Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens
P50
Q27650002-6DCCA283-7E7E-466C-9779-084B287E1513Q27667464-1679CF2F-91AB-4F12-8DD1-CE7AEFD0BB13Q30427641-584E0774-ED69-4CB3-99CC-2EFB6D69484EQ33583164-E1594919-0634-4A8E-900B-76496E2E336CQ33880228-0948CB64-43E4-416A-927B-4A5B5660797FQ33996850-C99A1D9E-2777-4B52-99A6-99B43AF3B35FQ34311559-0096CB5C-8270-4DFD-B505-A6C8EA6812ABQ35016816-F4046D47-715B-438B-93D9-BA03B6DB18DCQ35053984-79B29FC6-4F75-44F0-A3F6-1D671CF869F9Q35205128-6ACB27A9-A7C2-40C7-8736-522E820B7DDCQ35621805-41D0EAB7-7624-4ED5-90D0-D5C2FD5AF39CQ35826597-12F83074-22A4-42F8-BFA9-FB5F11BDD88DQ36072078-5CF9E65B-1D5E-47B2-8164-FA5AFB0BCC7AQ37009862-D09E73CB-C53F-4ABB-8F52-FCF986FC9BA3Q37074095-9581098E-DA28-42D0-BD98-BDBC0B660CBEQ37158836-090D44F9-FF37-4ED8-9B7A-58169A8261E5Q37182717-9C6C2647-B0C3-4BD1-9E9A-6D92E64C48EAQ37293365-2222BAD2-EBBD-4DF5-8400-DA70F11A7BC8Q37434351-2A401233-1ED6-4757-9594-AE91BDB5456EQ38076665-C15EA561-EB58-455C-B8F5-F84EA1184CC8Q38703436-70B0921F-CEDC-4516-B2B1-89D0AA10870BQ39559994-E6CF4464-0B64-4A80-96E3-08D4161C70CAQ39690857-4915FF3A-7E70-4494-A9D4-FB8D88DC8A77Q40086808-D65F7D48-FA34-45C9-9616-AF3628981D43Q40161196-4BC92300-CC29-4977-B190-6581C74BB8ECQ40320000-64055F92-0FFC-4F47-B0CB-1A044ACBF30FQ40409864-C7BF20AF-2C89-4D26-BD72-7C05AB1AADDCQ40606145-93A94A47-DDE9-41D9-BC82-E259D7590C93Q40638602-61163CF8-7AD2-46EB-AD55-F8D26076EC1DQ40955980-65A704C5-328A-43F9-8FF3-C439C2E33FB5Q41014695-E10E8F2D-8432-4684-95E0-92D15366B74FQ41042970-3D080924-3A1A-4229-B55A-51DB017A1788Q41144560-3421B521-6F87-47A5-9230-220795E92C70Q41426439-274C66CF-1899-4334-AB05-5D15C9A487BAQ41445687-DF94D45F-2208-47C0-992A-CE01125F1CFBQ41686178-775AC37D-8D00-44C0-8787-0D35DFE64BFDQ41748078-EE9EC669-65C7-48B4-9377-958A8607508DQ41987115-AF1D7F18-4872-49E5-8A42-284275398663Q42064852-94C5C221-43B7-4CFC-9874-5CDFECB423FDQ42741793-B088FAA3-B7BE-4C56-A148-38898DE90135
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Annelies S Zinkernagel
@ast
Annelies S Zinkernagel
@sl
Annelies S. Zinkernagel
@en
Annelies S. Zinkernagel
@eo
Annelies S. Zinkernagel
@es
Annelies S. Zinkernagel
@fr
Annelies S. Zinkernagel
@it
Annelies S. Zinkernagel
@nl
Annelies S. Zinkernagel
@sv
type
label
Annelies S Zinkernagel
@ast
Annelies S Zinkernagel
@sl
Annelies S. Zinkernagel
@en
Annelies S. Zinkernagel
@eo
Annelies S. Zinkernagel
@es
Annelies S. Zinkernagel
@fr
Annelies S. Zinkernagel
@it
Annelies S. Zinkernagel
@nl
Annelies S. Zinkernagel
@sv
altLabel
Annelies Sophie Zinkernagel
@en
Annelies Zinkernagel
@en
prefLabel
Annelies S Zinkernagel
@ast
Annelies S Zinkernagel
@sl
Annelies S. Zinkernagel
@en
Annelies S. Zinkernagel
@eo
Annelies S. Zinkernagel
@es
Annelies S. Zinkernagel
@fr
Annelies S. Zinkernagel
@it
Annelies S. Zinkernagel
@nl
Annelies S. Zinkernagel
@sv
P108
P1053
F-1780-2017
P106
P1153
15129227000
P21
P31
P3829
P496
0000-0003-4700-1118